Glycemic control in older adults: Applying recent evidence to clinical practice

Geriatrics and Aging

Volumn 12, Issue 3, 2009, Pages 130-134

  Sood, Ajay ^a   Aron, David C ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Diabetes; Glycemic control; Glycemic goal; Older adults

Indexed keywords

EID: 66149188151     PISSN: 14888408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998;21:C11-C14.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005.
3. Baines A. Treatment of hyperglycemia in the elderly. Geriatr Aging 2003;6:42-6.
4. Hornick T, Aron D. Managing diabetes in the elderly: go easy, individualize. Cleve Clin J Med 2008;75:70-8.
5. Segal A, Munshi M. Insulin therapy for older adults with diabetes. Geriatr Aging 2008;11:357-62.
6. Brown A, Mangione C, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003;51:S265-80.
7. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
8. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
9. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39.
10. Meneilly G, Tessier D. Diabetes in elderly adults. Sciences 2001;56A:M5-13.
11. Zammitt N, Frier B. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005;28:2948-61.
12. Pogach L, Brietzke S, Weinstock R, et al. Development of evidence-based guidelines for diabetes mellitus: the Veterans Health Administration-Department of Defense guidelines initiative. Diabetes Care 2004;27:B82-9.
13. Vijan S, Hofer T, Hayward R. Estimate benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997;127:788-95.
14. Bethel M, Sloan F, Belsky D, et al. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007;167:921-7.
15. Suh D, Kim C, Choi I, et al. Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus 1988 to 1994 to 2004. J Am Geriatr Soc 2008;56:484-92.
16. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006;29:1794-9.
17. Huang E, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008;149:11-9.
18. Huang E. Appropriate applications of evidence to the care of elderly patients with diabetes. Curr Diabetes Rev 2007;3:260-3.
19. Trief P, Morin P, Izquierdo R, et al. Depression and glycemic control in elderly ethnically diverse patients with diabetes: the IDEATel project. Diabetes Care 2006;29:830-5.
20. Sinclair A, Conroy S, Bayer A. Impact of diabetes on physical function in older adults. Diabetes Care 2008;31:233-5.
21. Hardy S, Gill T. Recovery from disability among community dwelling older persons. JAMA 2004;291:1596-602.
22. Boyd C, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005;294:716-24.
23. CDC Diabetes Cost-Effectiveness Study Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002;287:2542-51.
24. Chin M, Drum M, Jun L, et al. Variation in treatment preferences and care goals among older patients with diabetes and their physicians. Med Care 2008;46:275-86.
25. Aron DC, Pogach L. One size does not fit all: a continuous measure for glycemic control in diabetes: the need for a new approach to assessing glycemic control. Jt Comm J Qual Patient Saf 2007;33:636-43.
26. Diabetes Control and Complications Trial Research Group. The effects of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
27. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
28. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
29. Katz P, Gilbert J. Diabetes and cardiovascular disease among older adults: an update on the evidence. Geriatr Aging 2008;11:509-14.
30. Nathan D, Cleary P, Backlund J, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;22:2643-53.
31. Holman R, Paul S, Bethel M, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008;359:1576.
32. Skyler J, Bergenstal R, Bonow R, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and the VA diabetes trials. Diabetes Care 2009;32:187-92.
33. Gaede P, Lund-Andersen H, Parving H. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91.
34. Romney J. Diabetes and the Elderly Geriatrics Grand Rounds. Edmonton (AB): University of Alberta; 2008.
35. Hayward R, Hofer T, Vijan S. Intensive glucose control in elderly adults. JAMA 2007;297:2195-6.
36. Pogach L, Engelgau M, Aron D. Measuring progress towards achieving hemoglobin Alc goals: pass/fail or partial credit. JAMA 2007;297:520-3.